Non-invasive disease detection through a scan of the eye with Occuity

The UK Investor Magazine was thrilled to welcome Dan Daly, Founder & CEO of Occuity, and CCO Mark Jenkins to delve into Occuity’s eye scanning disease detection technology.

Find out more about Occuity on Republic here.

Occuity is developing handheld, non-contact devices that use the eye as a window to the body’s health.

The company’s patented optical technology already addresses glaucoma and myopia, while future products will target disease screening and, ultimately, a non-invasive glucose meter for diabetes monitoring.

Occuity enables screening of glaucoma, myopia and diabetes through optical MedTech backed by 15 patents and £4 million in grant funding. Its first product is selling globally through 19 distributors. The company has established a proven platform with a strategic pipeline of products in development.

The company has been busy forging commercial partnerships and is well placed to push forward with its growth strategy on the completion of their current fundraising round.

Hosted on Acast. See acast.com/privacy for more information.